表紙
市場調查報告書

C型肝炎:競爭環境分析·預測

Hepatitis C: Competitive Landscape to 2026

出版商 GlobalData 商品編碼 669400
出版日期 內容資訊 英文 49 Pages
訂單完成後即時交付
價格
C型肝炎:競爭環境分析·預測 Hepatitis C: Competitive Landscape to 2026
出版日期: 2018年06月30日內容資訊: 英文 49 Pages
簡介

本報告提供全球C型肝炎治療藥的市場調查,彙整疾病概要·流行病學,開發平台及臨床試驗趨勢,主要的已上市產品,目前主要企業與具有未來潛力的企業,市場上主要發展·預測等資料。

第1章 序文

第2章 摘要整理

第3章 簡介

  • 調查範圍
  • 疾病概要·流行病學

第4章 開發平台分析

  • 開發平台:概要
  • 開發平台的明細:各地各國
  • 開發平台的明細:分子類型·標的別
  • 藥物審查指定
  • 臨床開發中的產品

第5章 臨床試驗分析

  • 臨床試驗:概要
  • 臨床試驗的主要贊助商
  • 實驗的明細:各地區
  • 治療區域的展望
  • 編入分析

第6章 商業化分析

  • 主要的已上市產品
  • 現在·未來的企業

第7章 競爭環境分析·預測

  • 活動分類:概要
  • 主要7個國家
  • 新興市場 (巴西·中國)

第8章 附錄

本報告書的優點

  • 通過對管道產品和技術的審查,以及鎖定具有最強大管道的公司,開發和設計您的授權和授權策略。
  • 通過了解塑造和推動全球丙型肝炎市場的趨勢來制定業務戰略。
  • 通過了解未來可能影響全球丙型肝炎市場的關鍵趨勢,創新產品和技術,細分市場和公司來增加收入。
  • 通過了解競爭格局並分析各種競爭對手的表現,制定有效的銷售和營銷策略。
  • 確定具有潛在強大產品組合的新興參與者,並製定有效的反策略以獲得競爭優勢。
  • 通過確定為合併,投資和戰略合作夥伴關係提供最大機會的市場類別和細分市場,組織您的銷售和營銷工作。
目錄
Product Code: GDHC012CL

Hepatitis C is a liver infection caused by the hepatitis C virus (HCV), a small enveloped RNA virus. If left untreated, chronic infection can result in fibrosis, cirrhosis, hepatocellular carcinoma, and eventually death. HCV is spread primarily by exposure to infected blood.

This report provides an assessment of the pipeline, clinical, and commercial landscape of hepatitis C. Overall, GlobalData expects next-generation direc-acting antiviral (DAA) regimens to drive growth, with opportunities for new entrants residing primarily in emerging markets (Brazil and China) over the next decade (2016-2026).

Scope

This report combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace. Components of the slide deck include -

  • Pipeline Assessment: regional breakdown, promising late-stage products, early-stage pipeline by molecule type
  • Clinical Trials Assessment: trial breakdown by phase, leading industry and non-industry sponsors, enrollment analytics
  • Commercial Assessment: leading marketed products, current and future players
  • Competitive Landscape Analysis: key market events (2016-2026).

Reasons to buy

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the global hepatitis C market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global hepatitis C market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Table of Contents

1. Preface 2

  • 1.1 Table of Contents 2
  • 1.2 Abbreviations 3
  • 1.3 Related Reports 4
  • 1.4 Upcoming Related Reports 5

2. Executive Summary 6

  • 2.1 Key Findings 7
  • 2.2 Key Events 8

3. Introduction 9

  • 3.1 Report Scope 10
  • 3.2 Disease Overview and Epidemiology 12

4. Pipeline Assessment 16

  • 4.1 Pipeline Overview 17
  • 4.2 Pipeline Breakdown by Region/Country 19
  • 4.3 Pipeline Breakdown by Molecule Type and Target 20
  • 4.4 Drug Review Designations 21
  • 4.5 Products in Clinical Development 22

5. Clinical Trial Assessment 24

  • 5.1 Clinical Trials Overview 25
  • 5.2 Top Sponsors of Clinical Trials in MRSA 26
  • 5.3 Trial Breakdown by Region 28
  • 5.4 Therapy Area Perspective 29
  • 5.5 Enrollment Analytics 30

6 Commercial Assessment 33

  • 6.1 Leading Marketed Products 34
  • 6.2 Current & Future Players 35

7. Competitive Landscape Analysis (2016-2026) 36

  • 7.1 Events Classification Overview 37
  • 7.2 7MM 38
  • 7.3 Emerging Markets (Brazil and China) 39

8 Appendix 40

  • 8.1 Sources 41
  • 8.2 Methodology 42
  • 8.3 Key Events Included in the Analysis 43
  • 8.4 About the Authors 44
  • 8.5 About GlobalData 47
  • 8.6 Disclaimer 49